Home/Filings/4/A/0000899243-19-030128
4/A//SEC Filing

Goff MCF Partners, LP 4/A

Accession 0000899243-19-030128

CIK 0001071993other

Filed

Dec 26, 7:00 PM ET

Accepted

Dec 27, 7:13 PM ET

Size

60.6 KB

Accession

0000899243-19-030128

Insider Transaction Report

Form 4/AAmended
Period: 2019-12-19
GOFF JOHN C
10% Owner
Transactions
  • Other

    Common Stock

    2019-12-19+8,533,07210,846,008 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-197,832,71014,400,595 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19172,89011,687,805 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19691,55610,857,938 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-1969,15610,270,115 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-199,21110,153,230 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-193,68410,145,862 total(indirect: See footnote)
  • Purchase

    Series C Contingent Convertible Preferred Stock

    2019-12-19$2.50/sh+800,000$2,000,000800,000 total(indirect: See footnote)
    Common Stock (800,000 underlying)
  • Purchase

    Series C Contingent Convertible Preferred Stock

    2019-12-19$2.50/sh+200,000$500,000200,000 total(indirect: See footnote)
    Common Stock (200,000 underlying)
  • Other

    Common Stock

    2019-12-19+2,539,9002,612,664 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19+172,890172,890 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-192,539,90011,860,695 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19103,73310,754,205 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19207,46710,546,738 total(indirect: See footnote)
  • Purchase

    Series C Contingent Convertible Preferred Stock

    2019-12-19$2.50/sh+820,000$2,050,000820,000 total(indirect: See footnote)
    Common Stock (820,000 underlying)
  • Other

    Common Stock

    2019-12-19138,31111,549,494 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19207,46710,339,271 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19106,93710,163,178 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-191,84210,144,020 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19+7,832,7107,832,710 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-198,533,07222,233,305 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-1973710,162,441 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-193,68410,149,546 total(indirect: See footnote)
  • Purchase

    Series C Contingent Convertible Preferred Stock

    2019-12-19$2.50/sh+400,000$1,000,000400,000 total(indirect: See footnote)
    Common Stock (400,000 underlying)
Holdings
  • Common Stock

    3,571,786
  • Common Stock

    16,082
Transactions
  • Other

    Common Stock

    2019-12-19+7,832,7107,832,710 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19+8,533,07210,846,008 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-198,533,07222,233,305 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-193,68410,145,862 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19103,73310,754,205 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19207,46710,546,738 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19106,93710,163,178 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-191,84210,144,020 total(indirect: See footnote)
  • Purchase

    Series C Contingent Convertible Preferred Stock

    2019-12-19$2.50/sh+820,000$2,050,000820,000 total(indirect: See footnote)
    Common Stock (820,000 underlying)
  • Purchase

    Series C Contingent Convertible Preferred Stock

    2019-12-19$2.50/sh+800,000$2,000,000800,000 total(indirect: See footnote)
    Common Stock (800,000 underlying)
  • Other

    Common Stock

    2019-12-19+2,539,9002,612,664 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19+172,890172,890 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19138,31111,549,494 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-1969,15610,270,115 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-192,539,90011,860,695 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-197,832,71014,400,595 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19172,89011,687,805 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19207,46710,339,271 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-199,21110,153,230 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-193,68410,149,546 total(indirect: See footnote)
  • Purchase

    Series C Contingent Convertible Preferred Stock

    2019-12-19$2.50/sh+200,000$500,000200,000 total(indirect: See footnote)
    Common Stock (200,000 underlying)
  • Other

    Common Stock

    2019-12-19691,55610,857,938 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-1973710,162,441 total(indirect: See footnote)
  • Purchase

    Series C Contingent Convertible Preferred Stock

    2019-12-19$2.50/sh+400,000$1,000,000400,000 total(indirect: See footnote)
    Common Stock (400,000 underlying)
Holdings
  • Common Stock

    3,571,786
  • Common Stock

    16,082
Transactions
  • Other

    Common Stock

    2019-12-19+172,890172,890 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-192,539,90011,860,695 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19103,73310,754,205 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19207,46710,546,738 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19207,46710,339,271 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19+7,832,7107,832,710 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-197,832,71014,400,595 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19172,89011,687,805 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19691,55610,857,938 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-198,533,07222,233,305 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-1969,15610,270,115 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-1973710,162,441 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-193,68410,145,862 total(indirect: See footnote)
  • Purchase

    Series C Contingent Convertible Preferred Stock

    2019-12-19$2.50/sh+400,000$1,000,000400,000 total(indirect: See footnote)
    Common Stock (400,000 underlying)
  • Other

    Common Stock

    2019-12-19106,93710,163,178 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-199,21110,153,230 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-193,68410,149,546 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-191,84210,144,020 total(indirect: See footnote)
  • Purchase

    Series C Contingent Convertible Preferred Stock

    2019-12-19$2.50/sh+820,000$2,050,000820,000 total(indirect: See footnote)
    Common Stock (820,000 underlying)
  • Purchase

    Series C Contingent Convertible Preferred Stock

    2019-12-19$2.50/sh+800,000$2,000,000800,000 total(indirect: See footnote)
    Common Stock (800,000 underlying)
  • Purchase

    Series C Contingent Convertible Preferred Stock

    2019-12-19$2.50/sh+200,000$500,000200,000 total(indirect: See footnote)
    Common Stock (200,000 underlying)
  • Other

    Common Stock

    2019-12-19+8,533,07210,846,008 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19+2,539,9002,612,664 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19138,31111,549,494 total(indirect: See footnote)
Holdings
  • Common Stock

    3,571,786
  • Common Stock

    16,082
Transactions
  • Other

    Common Stock

    2019-12-19+8,533,07210,846,008 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19+172,890172,890 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-198,533,07222,233,305 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19103,73310,754,205 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-1973710,162,441 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19+7,832,7107,832,710 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-192,539,90011,860,695 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19207,46710,546,738 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-193,68410,145,862 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-191,84210,144,020 total(indirect: See footnote)
  • Purchase

    Series C Contingent Convertible Preferred Stock

    2019-12-19$2.50/sh+800,000$2,000,000800,000 total(indirect: See footnote)
    Common Stock (800,000 underlying)
  • Purchase

    Series C Contingent Convertible Preferred Stock

    2019-12-19$2.50/sh+200,000$500,000200,000 total(indirect: See footnote)
    Common Stock (200,000 underlying)
  • Other

    Common Stock

    2019-12-19+2,539,9002,612,664 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19172,89011,687,805 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19691,55610,857,938 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19106,93710,163,178 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-199,21110,153,230 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-197,832,71014,400,595 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19138,31111,549,494 total(indirect: See footnote)
  • Purchase

    Series C Contingent Convertible Preferred Stock

    2019-12-19$2.50/sh+820,000$2,050,000820,000 total(indirect: See footnote)
    Common Stock (820,000 underlying)
  • Other

    Common Stock

    2019-12-19207,46710,339,271 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-1969,15610,270,115 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-193,68410,149,546 total(indirect: See footnote)
  • Purchase

    Series C Contingent Convertible Preferred Stock

    2019-12-19$2.50/sh+400,000$1,000,000400,000 total(indirect: See footnote)
    Common Stock (400,000 underlying)
Holdings
  • Common Stock

    3,571,786
  • Common Stock

    16,082
Transactions
  • Other

    Common Stock

    2019-12-19+8,533,07210,846,008 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-197,832,71014,400,595 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19691,55610,857,938 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19103,73310,754,205 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-199,21110,153,230 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-191,84210,144,020 total(indirect: See footnote)
  • Purchase

    Series C Contingent Convertible Preferred Stock

    2019-12-19$2.50/sh+820,000$2,050,000820,000 total(indirect: See footnote)
    Common Stock (820,000 underlying)
  • Purchase

    Series C Contingent Convertible Preferred Stock

    2019-12-19$2.50/sh+800,000$2,000,000800,000 total(indirect: See footnote)
    Common Stock (800,000 underlying)
  • Purchase

    Series C Contingent Convertible Preferred Stock

    2019-12-19$2.50/sh+200,000$500,000200,000 total(indirect: See footnote)
    Common Stock (200,000 underlying)
  • Other

    Common Stock

    2019-12-19+7,832,7107,832,710 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-192,539,90011,860,695 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19207,46710,339,271 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19106,93710,163,178 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-193,68410,145,862 total(indirect: See footnote)
  • Purchase

    Series C Contingent Convertible Preferred Stock

    2019-12-19$2.50/sh+400,000$1,000,000400,000 total(indirect: See footnote)
    Common Stock (400,000 underlying)
  • Other

    Common Stock

    2019-12-19+172,890172,890 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19172,89011,687,805 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19138,31111,549,494 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19207,46710,546,738 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-1969,15610,270,115 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-1973710,162,441 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-193,68410,149,546 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19+2,539,9002,612,664 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-198,533,07222,233,305 total(indirect: See footnote)
Holdings
  • Common Stock

    3,571,786
  • Common Stock

    16,082
Transactions
  • Other

    Common Stock

    2019-12-193,68410,149,546 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-191,84210,144,020 total(indirect: See footnote)
  • Purchase

    Series C Contingent Convertible Preferred Stock

    2019-12-19$2.50/sh+820,000$2,050,000820,000 total(indirect: See footnote)
    Common Stock (820,000 underlying)
  • Other

    Common Stock

    2019-12-192,539,90011,860,695 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19172,89011,687,805 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19138,31111,549,494 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19103,73310,754,205 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19207,46710,339,271 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19106,93710,163,178 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-199,21110,153,230 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19+2,539,9002,612,664 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19+172,890172,890 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-197,832,71014,400,595 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19+8,533,07210,846,008 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19+7,832,7107,832,710 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-198,533,07222,233,305 total(indirect: See footnote)
  • Purchase

    Series C Contingent Convertible Preferred Stock

    2019-12-19$2.50/sh+400,000$1,000,000400,000 total(indirect: See footnote)
    Common Stock (400,000 underlying)
  • Purchase

    Series C Contingent Convertible Preferred Stock

    2019-12-19$2.50/sh+800,000$2,000,000800,000 total(indirect: See footnote)
    Common Stock (800,000 underlying)
  • Purchase

    Series C Contingent Convertible Preferred Stock

    2019-12-19$2.50/sh+200,000$500,000200,000 total(indirect: See footnote)
    Common Stock (200,000 underlying)
  • Other

    Common Stock

    2019-12-19691,55610,857,938 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-19207,46710,546,738 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-1969,15610,270,115 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-1973710,162,441 total(indirect: See footnote)
  • Other

    Common Stock

    2019-12-193,68410,145,862 total(indirect: See footnote)
Holdings
  • Common Stock

    16,082
  • Common Stock

    3,571,786
Footnotes (10)
  • [F1]These securities are held directly by the the John C. Goff 2010 Family Trust (the Trust). John C. Goff is the trustee of the Trust and, as such, he may be deemed to beneficially own the securities held by the Trust.
  • [F10]The Series C Preferred Stock has no expiration date.
  • [F2]These securities are held directly by Goff Family Investments, LP (Goff Investments). Goff Capital, Inc. (Goff Capital) is the general partner of Goff Investments and, as such, it may be deemed to beneficially own the securities held by Goff Investments. The Trust is the controlling shareholder of Goff Capital and, as such, it may be deemed to beneficially own the securities held by Goff Capital. John C. Goff is the trustee of the Trust and, as such, he may be deemed to beneficially own the securities held by the Trust.
  • [F3]These securities are held directly by JCG 2016 Holdings, LP (JCG Holdings). JCG 2016 Management, LLC (JCG Management) is the general partner of JCG Holdings and, as such, it may be deemed to beneficially own the securities held by JCG Holdings. John C. Goff is the manager of JCG Management, and, as such, he may be deemed to beneficially own the securities held by JCG Management.
  • [F4]These securities are held directly by Kulik Partners, LP (Kulik Partners). Kulik GP, LLC (Kulik GP) is the general partner of Kulik Partners and, as such, may be deemed to beneficially own the securities held by Kulik Partners. John C. Goff is the manager of Kulik GP, and, as such, he may be deemed to beneficially own the securities held by Kulik GP.
  • [F5]The Common Stock directly held by John C. Goff. The Common Stock was issued directly to Mr. Goff in connection with his service as a member of the board of directors of the Issuer.
  • [F6]These securities are held directly by Goff MCF Partners, LP (Goff MCF). GFS Contango GP, LLC (GFS Contango) is the general partner of Goff MCF, and, as such, it may be deemed to beneficially own the securities held by Goff MCF. GFS Management, LLC (GFS Management) is the managing member of GFS Contango and, as such, it may be deemed to beneficially own the securities held by GFS Contango. Goff Focused Strategies LLC (GFS) is the managing member of GFS Management and, as such, it may be deemed to beneficially own the securities held by GFS Management. GFT Strategies, LLC (GFT) is the controlling equity holder of GFS and, as such, it may be deemed to beneficially own the securities held by GFS. The Trust is the managing member of GFT and, as such, it may be deemed to beneficially own the securities held by GFT. John C. Goff is the trustee of the Trust and, as such, he may be deemed to beneficially own the securities held by the Trust.
  • [F7]Represents a pro rata distribution, and not a purchase or sale, without additional consideration by Goff MCF to its limited partners. Each of the Trust, Goff Investments, JCG Holdings and Kulik Partners received shares of Common Stock from Goff MCF in connection with the distribution.
  • [F8]Prior to the disposition, these securities were held directly by Goff MCF.
  • [F9]The Series C Preferred Stock is convertible into shares of Common Stock on a one-for-one basis upon the approval by the shareholders of the Issuer, in accordance with applicable law and the applicable rules and regulations of the principal national securities exchange on which the Common Stock is listed for trading.

Issuer

CONTANGO OIL & GAS CO

CIK 0001071993

Entity typeother
IncorporatedTX

Related Parties

1
  • filerCIK 0001743422

Filing Metadata

Form type
4/A
Filed
Dec 26, 7:00 PM ET
Accepted
Dec 27, 7:13 PM ET
Size
60.6 KB